Connect with us

Business

HempAmericana Inc (OTCMKTS:HMPQ): Do the Math

Published

on

HempAmericana Inc (OTCMKTS:HMPQ) would appear to be mispriced according to a basic interpretation of the company’s recent communications and the overall industry and market context in which it exists. This conclusion is driven by the sense that the CBD, hemp, and cannabis space has probably bottomed, and that HMPQ is probably verging on appreciable and tangible sales growth in a manner and to a degree that the market will no longer be able to ignore.

Let’s first turn to the former of these allegations: the CBD, hemp, and cannabis space has probably bottomed.

 

The Big Green Turn

It’s important to understand that, by this idea of a “bottom” in the green machine, we mean a cyclical inflection from the longstanding 18-month bear market to a new bull cycle that sees the stocks in the space, including HempAmericana, witness powerful price-per-share appreciation.

The driver is partly seasonal, partly situational, and partly cyclical.

The seasonal influence is rooted in the fact that some significant portion of the cannabis cash crop is brought to market from outdoor growers (as opposed to greenhouse and indoor growers), who are now just starting to tend to the crops that will become the fall harvest. In other words, the supply of cannabis coming to market has started to become seasonally reduced during the period from April to October, meaning that we are now in the early stages of that seasonal dip in supply.

Situationally, demand for cannabis is clearly on the upswing during the stay-at-home coronavirus response. This is due to some presumed combination of anxiety and boredom.

Finally, the CBD, hemp, and cannabis space had already been through an extreme ringer by the time we hit the broad coronavirus bear market. In other words, we had already whittled down the stocks in this space to bare bones when the broad market wind started to blow. That likely over-exaggerated the dynamic, driving these stocks to an undervalued threshold – an overextension of the downward trend.

 

The Stars Align

At the same time that we are starting to see the right type of signals to suggest that money will likely be flowing back into CBD and hemp plays in coming months, we are also seeing the right type of signals from HMPQ: the ecommerce engine is up and running live with a payment processor capable of taking payments from all popular methods of commerce, the company is partnering with Alibaba’s winning B2B platform as a supplier, HempAmericana just gobbled up a vast affiliate marketing network of over 400 relevant domains and sites to point back to its store, and just made important announcements about beefing up its marketing and customer service capabilities.

All of this comes on the heels of news that it had built up a strong inventory of high-quality CBD products and after constructing a truly state-of-the-art extraction and production facility in Maine with a supply chain already in place.

Those are really all of the pieces to churning out really nice financials over coming quarters and it puts the company in a place it has never been before – prepotency across the board.

To help add some extra juice and get the ball rolling on the top line, the company also just announced that it is now marketing its products on the Groupon platform.

“As part of our aggressive pursuit of brand and product sales growth, we are launching a promotional campaign designed to create further market penetration through the largest digital coupon platform on the planet,” commented Salvador Rosillo, CEO of HempAmericana. “Millions of people search for deals on Groupon, providing us with a resource for generating immediate sales growth and relationships with new customers that hold the potential for repeat business for years to come.”

 

This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Business

Singlepoint Inc. (OTCMKTS: SING) In A Joint Venture With Box Biosciences To Produce and Distribute Hand Sanitizers

Published

on

Singlepoint Inc. (OTCMKTS:SING) has formed a joint venture with BOX Biosciences to distribute various hand-sanitizer products produced in Carlsbad, California.

Singlepoint joint venture producing FDA-approved sanitizer

The two companies are distributing the FDA-approved sanitizer products on the west and east coast. BOX Biosciences is headquartered in Charleston, South Carolina, with distribution outlets in Raleigh, North Carolina, and Carlsbad, California. Following the coronavirus outbreak, there has been a shortage of disinfectant and sanitizer products.

Because of the urgent need to fill this shortage, the companies through the joint venture are working to ensure the US is safe by producing bulk hand sanitizers. They will also introduce disinfectants as permitted by the demand of hand sanitizers. Already the companies have on-going sales to various retail outlets, and currently, they are in discussions for potential hand sanitizer product sales.

The sanitizers the companies are manufacturing kill 99.9% of coronavirus causing germs, and they will be available to the general public and essential businesses. For now, the companies have prioritized the sanitizers to nursing homes, clinics, hospitals, government units, and home healthcare agencies. Equally essential businesses will also get prioritized in getting the bulk hand sanitizers.

Singlepoint and Box committed to offering solutions to COVID-19

Ryan Cowell, the founder of BOX Biosciences, indicated that they will focus on bulk orders of 250 gallons, 55-gallon drums, 1 gallon, 1 liter, 32oz, and 8oz totes of sanitizer. For businesses having the ability to offload bulk sanitizer from tankers, they can also order.

Singlepoint and Box’s expansion to making disinfectant and hand sanitizers shows how companies are dedicated to offering significant well-being solutions for the environment, surfaces, and people in response to the COVID-19 outbreak.

BOX’s operations manager Troy Lorenz stated there is an urge by businesses and people to clean and disinfect their work environment, and as a result, the products they are producing are important for the environment and people. The objective of Singlepoint and Box is to help authorities and people in combating the spread of COVID-19.

Continue Reading

Business

Sproutly Canada Inc (OTCMKTS:SRUTF) Chalks Out A Business Strategy To Focus On Commercialization Of APP Technology

Published

on

Sproutly Canada Inc (OTCMKTS:SRUTF) has chalked out a business transformation strategy to focus on commercializing its proprietary APP technology by moving away from cannabis cultivation resources. Infusion Biosciences Inc will contribute additional funds to implement business transformation. It will also supply additional talent to support the transformation plan.

Business transformation strategy

As part of the light technology model, Sproutly will focus on generating revenues through establishing ingredient supply agreements, technology licensing, and partnership opportunities. It will scale down the cultivation of cannabis, which is capital intensive, and reduce cash burn.

Sproutly has recruited Dr. Anup Sen as Chief Executive Officer for implementing a business transformation plan. Anup is the first scientist to invent water soluble CBD in cannabis plants. Following the appointment of Dr. Anup, Keith Dolo is relinquishing the post of CEO. Keith will also step down from the board of Sproutly. He will act as an advisor to the Chairman. Keith said the company’s main target is to introduce unique products in the market by using APP Technology. Sproutly also slashed cash expenses by giving pink slips to operational and corporate staff.

Sproutly is adopting the new business strategy because of the operational challenges and headwinds in the industry. Prohibitive costs associated with cannabis cultivation have forced the company to change its business strategy.

Commercializes APP technology

Sproutly will focus on APP technology commercialization through formulation, production, and the sale of ingredients by using Bi-Natural Oils and water-soluble cannabinoids. The company will use the licensed manufacturers’ distribution networks and its existing infrastructure to realize its revised plan. Sproutly has faced bottlenecks in introducing cannabis 2.0 products because it has earmarked human resources and significant capital for cannabis cultivation.

Adopts cost-cutting measures

Sproutly has reduced the employees by 75% to reduce costs and reduce cannabis cultivation. It has eased the capital requirements for Sproutly and pursues other strategic alternatives. The company will get the support of six key personnel of Infusion Biosciences to assist in its daily operations.

Infusion Biosciences’s key executives have helped Sproutly in obtaining licenses for APP technology and in forming partnerships in the US. Sproutly also expects to expedite its commercialization efforts with the help of these executives.

Continue Reading

Business

Aleafia Health Inc (OTCMKTS:ALEAF) Reports An Astonishing 2,486% Rise In Q1 2020 Revenues

Published

on

Aleafia Health Inc (OTCMKTS:ALEAF) has reported revenues of $14.59 million in Q1 2020. It is an increase of 2,486% compared to the same period last year and a 143% increase compared to the previous quarter.

Reports solid growth for the fifth consecutive quarter

Geoffrey Benic, Chief Executive Officer of Aleafia, said the company achieved a breakthrough in Q1 2020 on the backdrop of sustainable and disciplined growth. As it builds the cannabis wellness and health ecosystem, the company gives importance to the patient-centric approach. It is the fifth consecutive quarter to report solid growth.

Expects to introduce new cannabis 2.0 products in H2

Aleafia expects to introduce new cannabis 2.0 products tailored for the wellness and health consumers in H2, 2020. Its active registered patient count has surged to 10,983 as of March 31, 2020, from 10,249 as of December 31, 2019.

Key achievements in Q1 2020

Aleafia on March 26, 2020, announced plans to introduce direct-to-door medical cannabis delivery service to the registered patients. It is a contactless and safe delivery mechanism for the patients. Therefore, Aleafia eliminates the need for collecting the products from post boxes and post offices.

Achievements after Q1 2020

According to the announcement on May 1, 2020, Glenn Washer and Rhonda Lawson will be appointed to the board with effect from May 16, 2020. It is on the backdrop of the resignation of the existing directors – Bill Stewart, and Raf Souccar with effective from May 15, 2020. Julian Fantino, Chairman, has also resigned from the board.

Aleafia has temporarily shut down its physical offices of the education centers and cannabis clinics across the nation since March 16, 2020, because of the ongoing coronavirus crisis. The company is completing the patient consultations via its virtual clinics.

To maintain long term success, the company maintains a diversified portfolio of differentiated and high-quality product formats. The company will use in-house facilities to manufacture cannabis 2.0 products and satisfy the demand in the medical and adult-use cannabis markets in Canada. It will also supply cannabis 2.0 products in markets worldwide where legally permitted.

Aleafia Farms Inc, a wholly-owned subsidiary of Aleafia, has secured an amended license from Health Canada on May 12, 2020, for the outdoor cultivation at its Port Perry Facility.

Continue Reading
Advertisement

Whats Hot